212 related articles for article (PubMed ID: 35064062)
21. HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes.
Chatfield-Reed K; Gui S; O'Neill WQ; Teknos TN; Pan Q
Oral Oncol; 2020 Jan; 100():104488. PubMed ID: 31835137
[TBL] [Abstract][Full Text] [Related]
22. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus and head and neck squamous cell carcinoma in a UK population: Is there an association?
Al-Dabbagh R; Al-Hazmi N; Alhazzazi TY; Barrett AW; Speight PM
Indian J Cancer; 2022; 59(1):65-72. PubMed ID: 33753602
[TBL] [Abstract][Full Text] [Related]
24. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
Báez A; Cantor A; Fonseca S; Marcos-Martinez M; Mathews LA; Muro-Cacho CA; Muñoz-Antonia T
Clin Cancer Res; 2005 May; 11(9):3191-7. PubMed ID: 15867212
[TBL] [Abstract][Full Text] [Related]
25. Gene expression profiles in HPV-infected head and neck cancer.
Schlecht NF; Burk RD; Adrien L; Dunne A; Kawachi N; Sarta C; Chen Q; Brandwein-Gensler M; Prystowsky MB; Childs G; Smith RV; Belbin TJ
J Pathol; 2007 Nov; 213(3):283-93. PubMed ID: 17893858
[TBL] [Abstract][Full Text] [Related]
26. Characterization of gene methylation in human papillomavirus associated-head and neck squamous cell carcinoma.
Zhang HZ; Shan CG; Huang AP; Wang JM
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706614
[TBL] [Abstract][Full Text] [Related]
27. High-risk HPV types and head and neck cancer.
Michaud DS; Langevin SM; Eliot M; Nelson HH; Pawlita M; McClean MD; Kelsey KT
Int J Cancer; 2014 Oct; 135(7):1653-61. PubMed ID: 24615247
[TBL] [Abstract][Full Text] [Related]
28. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
[TBL] [Abstract][Full Text] [Related]
29. Single-Cell Transcriptome Analysis Reveals Different Immune Signatures in HPV- and HPV + Driven Human Head and Neck Squamous Cell Carcinoma.
Li S; Wang Y; Sun R; Franceschi D; Pan H; Wei C; Ogbuehi AC; Lethaus B; Savkovic V; Gaus S; Zimmerer R; Ziebolz D; Schmalz G; Jiang X
J Immunol Res; 2022; 2022():2079389. PubMed ID: 36157879
[TBL] [Abstract][Full Text] [Related]
30. DEK promotes HPV-positive and -negative head and neck cancer cell proliferation.
Adams AK; Hallenbeck GE; Casper KA; Patil YJ; Wilson KM; Kimple RJ; Lambert PF; Witte DP; Xiao W; Gillison ML; Wikenheiser-Brokamp KA; Wise-Draper TM; Wells SI
Oncogene; 2015 Feb; 34(7):868-77. PubMed ID: 24608431
[TBL] [Abstract][Full Text] [Related]
31. Deciphering head and neck cancer microenvironment: Single-cell and spatial transcriptomics reveals human papillomavirus-associated differences.
Lee H; Park S; Yun JH; Seo C; Ahn JM; Cha HY; Shin YS; Park HR; Lee D; Roh J; Heo HJ; Baek SE; Kim EK; Lee HS; Kim CH; Kim YH; Jang JY
J Med Virol; 2024 Jan; 96(1):e29386. PubMed ID: 38235919
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
[TBL] [Abstract][Full Text] [Related]
33. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck.
Begum S; Gillison ML; Nicol TL; Westra WH
Clin Cancer Res; 2007 Feb; 13(4):1186-91. PubMed ID: 17317828
[TBL] [Abstract][Full Text] [Related]
34. Molecular heterogeneity of head and neck squamous cell carcinoma defined by next-generation sequencing.
Zhang P; Mirani N; Baisre A; Fernandes H
Am J Pathol; 2014 May; 184(5):1323-30. PubMed ID: 24767105
[TBL] [Abstract][Full Text] [Related]
35. High Risk-Human Papillomavirus in HNSCC: Present and Future Challenges for Epigenetic Therapies.
Ghiani L; Chiocca S
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408843
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.
Salazar CR; Smith RV; Garg MK; Haigentz M; Schiff BA; Kawachi N; Anayannis N; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
Head Neck Pathol; 2014 Mar; 8(1):77-87. PubMed ID: 24002971
[TBL] [Abstract][Full Text] [Related]
37. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
[TBL] [Abstract][Full Text] [Related]
38. Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma.
Zhou Q; Yuan O; Cui H; Hu T; Xiao GG; Wei J; Zhang H; Wu C
Front Cell Infect Microbiol; 2022; 12():1007950. PubMed ID: 36425786
[TBL] [Abstract][Full Text] [Related]
39. 5-Hydroxymethylation highlights the heterogeneity in keratinization and cell junctions in head and neck cancers.
Liu S; de Medeiros MC; Fernandez EM; Zarins KR; Cavalcante RG; Qin T; Wolf GT; Figueroa ME; D'Silva NJ; Rozek LS; Sartor MA
Clin Epigenetics; 2020 Nov; 12(1):175. PubMed ID: 33203436
[TBL] [Abstract][Full Text] [Related]
40. LncRNAs as an intermediate in HPV16 promoting myeloid-derived suppressor cell recruitment of head and neck squamous cell carcinoma.
Ma X; Sheng S; Wu J; Jiang Y; Gao X; Cen X; Wu J; Wang S; Tang Y; Tang Y; Liang X
Oncotarget; 2017 Jun; 8(26):42061-42075. PubMed ID: 28159935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]